Article Information
History
- April 20, 2022.
Article Versions
- Version 1 (February 6, 2021 - 18:24).
- Version 2 (February 9, 2021 - 03:24).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Daniel J. M. Crouch1,
- Jamie R.J. Inshaw1,
- Catherine C. Robertson2,
- Jia-Yuan Zhang1,
- Wei-Min Chen2,3,
- Suna Onengut-Gumuscu2,3,
- Antony J. Cutler1,
- Carlo Sidore4,
- Francesco Cucca4,
- Flemming Pociot5,6,7,
- Patrick Concannon8,9,
- Stephen S. Rich2,3 and
- John A. Todd1,*
- 1JDRF/Wellcome Diabetes and Inflammation Laboratory, Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
- 2Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA
- 3Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA
- 4Institute for Research in Genetics and Biomedicine (IRGB), Sardinia, Italy
- 5Department of Pediatrics, Herlev University Hospital, Copenhagen, Denmark
- 6Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 7Type 1 Diabetes Biology, Department of Clinical Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark
- 8Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA
- 9Genetics Institute, University of Florida, Gainesville, Florida, USA
- ↵*Corresponding author: John Todd (jatodd{at}well.ox.ac.uk), Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford